Abstract
Cardiopulmonary bypass (CPB) recovery is complicated by lung inflammation from bone marrow (BM)-derived polymorphonuclear leukocytes (PMNs) and monocytes (MO). Although Sivelestat reduces inflammatory mediators and Rolipram inhibits PMN and MO activation, any kinetic effects to improve CPB recovery in vivo are unknown. We hypothesized that intraoperative co-administration of these compounds would reduce CPB-induced lung inflammation through downregulation of PMN and MO recruitment. A 2-h CPB was surgically established in cynomolgus monkeys (n = 13), and BM leukocyte release and lung recruitment were monitored postoperatively by flow cytometry with 5′-bromo-2′-deoxyuridine (BrdU) and cytokine ELISA. Either Sivelestat, Sivelestat plus Rolipram, or saline (control) was administered intraoperatively and both peripheral and perfusion sampling courses revealed BrdU-labeled cells representative of activated leukocyte infiltration. Levels of cytokines CD11b and CD18 were leukocytic activation markers. Sivelestat plus Rolipram attenuated increases in CPB-associated circulating band cells, prolonged BM-transit time (PMN: 121.0 ± 3.7 to 96.2 ± 4.3 h [control], p = 0.012; MO: 84.4 ± 4.1 to 61.4 ± 3.0 h [control], p = 0.003), and reduced their alveolar appearance. CD11b-mediated PMN and MO changes during CPB and the post-surgical increases of Interleukin (IL)-6 and IL-8 in the bronchoalveolar lavage fluid were suppressed. Sivelestat alone increased PMN transit time to 115.8 ± 6.6 h, but monocytes were unaffected. Therefore, Rolipram has additive inhibitory effects with Sivelestat on the CPB-induced activation and release of BM-derived PMNs and MO and their recruitment to the lungs. Co-administration of these compounds could, therefore, hold value for preventing CPB-induced lung injury.
Similar content being viewed by others
References
Goto Y, Hiramatsu Y, Ageyama N, Sato S, Kanemoto S, Sato Y, et al. Cardiopulmonary bypass induces recruitment of bone marrow-derived leukocytes to the lungs in monkeys. Ann Thorac Surg. 2014;97:617–22.
van Eeden SF, Kitagawa Y, Klut ME, Lawrence E, Hogg JC. Polymorphonuclear leukocytes released from the bone marrow preferentially sequester in lung microvessels. Microcirculation. 1997;4:369–80.
Edmunds LH. Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1998;66:S12-6 (discussion S25–8)
Johnson D, Thomson D, Hurst T, Prasad K, Wilson T, Murphy F, et al. Neutrophil-mediated acute lung injury after extracorporeal perfusion. J Thorac Cardiovasc Surg. 1994;107:1193–202.
Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365–76.
Matsuzaki K, Hiramatsu Y, Homma S, Sato S, Shigeta O, Sakakibara Y. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg. 2005;80:611–7.
Sato Y, Hiramatsu Y, Homma S, Sato M, Sato S, Endo S, et al. Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation. J Thorac Cardiovasc Surg. 2005;130:346–50.
Sato Y, Hiramatsu Y, Homma S, Sato S, Onizuka M, Sakakibara Y. Phosphodiesterase type 4 inhibition of activated polymorphonuclear leukocytes in a simulated extracorporeal circulation model. J Thorac Cardiovasc Surg. 2003;125:172–7.
Yoshimura Y, Hiramatsu Y, Sato Y, Homma S, Enomoto Y, Jikuya T, et al. ONO-6818, a novel, potent neutrophil elastase inhibitor, reduces inflammatory mediators during simulated extracorporeal circulation. Ann Thorac Surg. 2003;76:1234–9.
Torphy TJ. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med. 1998;157:351–70.
Sayeed MM. Exuberant Ca(2+) signaling in neutrophils: a cause for concern. News Physiol Sci. 2000;15:130–6.
Zeiher BG, Artigas A, Vincent JL, Dmitrienko A, Jackson K, Thompson BT, et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med. 2004;32:1695–702.
Honjo S. The Japanese Tsukuba Primate Center for Medical Science (TPC): an outline. J Med Primatol. 1985;14:75–89.
Japan PSo. Guiding principles for animal experiments using nonhuman primates. Primate Res. 1986;2:111–3.
Goto Y, Hogg JC, Suwa T, Quinlan KB, van Eeden SF. A novel method to quantify the turnover and release of monocytes from the bone marrow using the thymidine analog 5′-bromo-2′-deoxyuridine. Am J Physiol Cell Physiol. 2003;285:C253-9.
Finn A, Morgan BP, Rebuck N, Klein N, Rogers CA, Hibbs M, et al. Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;111:451–9.
Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;105:234–41.
Ishikawa N, Oda M, Kawaguchi M, Tsunezuka Y, Watanabe G. The effects of a specific neutrophil elastase inhibitor (ONO-5046) in pulmonary ischemia-reperfusion injury. Transpl Int. 2003;16:341–6.
Yamazaki T, Ooshima H, Usui A, Watanabe T, Yasuura K. Protective effects of ONO-5046-Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann Thorac Surg. 1999;68:2141–6.
Inoue Y, Seiyama A, Tanaka H, Ukai I, Akimau P, Nishino M, et al. Protective effects of a selective neutrophil elastase inhibitor (sivelestat) on lipopolysaccharide-induced acute dysfunction of the pulmonary microcirculation. Crit Care Med. 2005;33:1814–22.
Suwa T, Hogg JC, English D, Van Eeden SF. Interleukin-6 induces demargination of intravascular neutrophils and shortens their transit in marrow. Am J Physiol Heart Circ Physiol. 2000;279:H2954-60.
Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068–101.
Doerschuk CM. The role of CD18-mediated adhesion in neutrophil sequestration induced by infusion of activated plasma in rabbits. Am J Respir Cell Mol Biol. 1992;7:140–8.
Le Deist F, Menasche P, Kucharski C, Bel A, Piwnica A, Bloch G. Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion. A clinical study. Circulation. 1995;92:II354–8.
Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood. 1992;79:1201–5.
Acknowledgements
The authors thank Yuko Katakai and Hiromi Ogawa at the Corporation for Production and Research of Laboratory Primates for technical support. This work was supported by Grants-in-Aid for Scientific Research (Grant number 16K15757 to Dr. Goto and 23390332 to Dr. Hiramatsu) from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Goto, Y., Hiramatsu, Y., Ageyama, N. et al. Rolipram plus Sivelestat inhibits bone marrow-derived leukocytic lung recruitment after cardiopulmonary bypass in a primate model. J Artif Organs 22, 44–52 (2019). https://doi.org/10.1007/s10047-018-1071-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-018-1071-0